A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin

NCT04059588 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Solid Tumor
Cancer of Skin

Interventions

DRUG: 2141 V-11

Sponsor

Rockefeller University